Seguir
Evan Christopher Lam
Evan Christopher Lam
Senior Research Technologist, Ragon Institute of MGH, MIT, and Harvard
Dirección de correo verificada de MGH.Harvard.edu
Título
Citado por
Citado por
Año
Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity
WF Garcia-Beltran, EC Lam, KS Denis, AD Nitido, ZH Garcia, BM Hauser, ...
Cell 184 (9), 2372-2383. e9, 2021
16422021
COVID-19-neutralizing antibodies predict disease severity and survival
WF Garcia-Beltran, EC Lam, MG Astudillo, D Yang, TE Miller, J Feldman, ...
Cell 184 (2), 476-488. e11, 2021
7382021
Quick COVID-19 healers sustain anti-SARS-CoV-2 antibody production
Y Chen, A Zuiani, S Fischinger, J Mullur, C Atyeo, M Travers, FJN Lelis, ...
Cell 183 (6), 1496-1507. e16, 2020
2042020
Reduced BNT162b2 Messenger RNA Vaccine Response in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)–Naive Nursing Home Residents
DH Canaday, L Carias, OA Oyebanji, D Keresztesy, D Wilk, M Payne, ...
Clin Infect Dis 16, 2021
562021
Naive human B cells engage the receptor binding domain of SARS-CoV-2, variants of concern, and related sarbecoviruses
J Feldman, J Bals, CG Altomare, K St. Denis, EC Lam, BM Hauser, ...
bioRxiv, 2021.02. 02.429458, 2021
542021
Reduced BNT162b2 mRNA vaccine response in SARS-CoV-2-naive nursing home residents
DH Canaday, L Carias, O Oyebanji, D Keresztesy, D Wilk, M Payne, ...
medRxiv, 2021
522021
The persistence of interleukin-6 is regulated by a blood buffer system derived from dendritic cells
AS Yousif, L Ronsard, P Shah, T Omatsu, M Sangesland, TB Moreno, ...
Immunity 54 (2), 235-246. e5, 2021
412021
Significant reduction in humoral Immunity among healthcare workers and nursing home residents 6 months AFTER COVID-19 BNT162b2 mRNA vaccination
DH Canaday, O Oyebanji, D Keresztesy, M Payne, D Wilk, L Caris, ...
MedRxiv, 2021
182021
Engineered receptor binding domain immunogens elicit pan-sarbecovirus neutralizing antibodies outside the receptor binding motif
BM Hauser, M Sangesland, EC Lam, KJS Denis, J Feldman, AS Yousif, ...
bioRxiv, 0
17
Circulating SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity
WF Garcia-Beltran, EC Lam, KS Denis, AD Nitido, ZH Garcia, BM Hauser, ...
MedRxiv, 2021
14*2021
Naive human B cells can neutralize SARS-CoV-2 through recognition of its receptor binding domain
J Feldman, J Bals, KS Denis, EC Lam, BM Hauser, L Ronsard, ...
bioRxiv, 2021
82021
High-resolution sequencing of viral populations during early simian immunodeficiency virus infection reveals evolutionary strategies for rapid escape from emerging Env-specific …
S Ita, AK Hill, EC Lam, FJ Dufort, X Yang, R Newman, S Leviyang, ...
Journal of virology 92 (7), e01574-17, 2018
52018
Rationally designed immunogens enable immune focusing to the SARS-CoV-2 receptor binding motif
BM Hauser, M Sangesland, KS Denis, J Feldman, EC Lam, T Kannegieter, ...
bioRxiv, 2021
32021
Immunogenicity of mRNA-1273, BNT162b2 and Ad26. COV2. S COVID-19 vaccines
V Naranbhai, WF Garcia-Beltran, CB Mairena, JC Thierauf, CC Chang, ...
medRxiv, 2021
22021
High-Resolution Sequencing of Viral Populations During Early SIV Infection Reveals Evolutionary Strategies for Rapid Escape from Emerging Env-Specific Antibody Responses
S Ita, AK Hill, EC Lam, FJ Dufort, X Yang, R Newman, S Leviyang, ...
Journal of Virology, 2018
22018
Engineered Receptor Binding Domain Immunogens Elicit Pan-Coronavirus Neutralizing Antibodies Outside the Receptor Binding Motif
BM Hauser, M Sangesland, EC Lam, J Feldman, AS Yousif, ...
Available at SSRN 3773801, 2021
2021
Engineered receptor binding domain immunogens elicit pan-coronavirus neutralizing antibodies
BM Hauser, M Sangesland, EC Lam, J Feldman, AS Yousif, ...
bioRxiv, 2020
2020
Defining and Characterizing the'Escapability'of Potent Broadly Neutralizing Antibodies Against HIV in Humanized Mice
C Deal, Y Soto-Albrecht, S MacDonald, C Boutros, E Lam, B Moon, ...
AIDS RESEARCH AND HUMAN RETROVIRUSES 34, 78-78, 2018
2018
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–18